We have observed
13 EP applications
Jonathan Simon Thwaite
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after January 13, 2014).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
USE OF PHOSPHO-AKT AS A BIOMARKER OF DRUG RESPONSE
INSECTICIDAL COMPOUNDS BASED ON ARYLTHIOACETAMIDE DERIVATIVES
PESTICIDAL MIXTURES COMPRISING ISOXAZOLINE DERIVATIVES
PESTICIDAL MIXTURES INCLUDING ISOXAZOLINE DERIVATIVES
COMBINATION THERAPY FOR THE TREATMENT OF CANCER AND IMMUNOSUPPRESSION
PROCESS FOR THE MANUFACTURE OF ISAVUCONAZOLE OR RAVUCONAZOLE
SELECTED MACROLIDES WITH PDE4-INHIBITING ACTIVITY
PROCESS FOR THE PREPARATION OF 8-(4-AMINOPHENOXY)-4H-PYRIDO[2,3-B]PYRAZIN-3-ONE DERIVATIVES
SUBSTITUTED MONO- AND POLYAZANAPHTHALENE DERIVATIVES AND THEIR USE
EFFLUX-PUMP INHIBITORS AND THERAPEUTIC USES THEREOF
USE OF EB1 AS A BIOMARKER OF DRUG RESPONSE